Ceragon Secures $4.1 Million Agreement to Power Mission-Critical Infrastructure for Leading North American Oil & Gas Producer
Ceragon to deliver turnkey industrial connectivity and infrastructure solutions for essential operations ROSH HA‘AIN, Israel, April 30, 2025 /PRNewswire/ — Ceragon... Read more.
Internova Travel Group to Host I AM C.U.L.T.U.R.E.D. Youth Travel & Career Summit on May 3
Daylong event is designed to introduce high school students of color to travel opportunities, careers in the industry NEW YORK, April 30, 2025 /PRNewswire/ —... Read more.
NOVA Infrastructure Invests in DartPoints to Accelerate Growth and Expand Strategic Infrastructure
DartPoints owns and operates colocation data centers across ten Tier 2 and Tier 3 markets NEW YORK and DALLAS, April 30, 2025 /PRNewswire/ — NOVA Infrastructure... Read more.
Anytime AI Partners with Stark & Stark, PC to Accelerate Legal Workflow Innovation Using Next-Gen AI Technology
WHITE PLAINS, N.Y., April 30, 2025 /PRNewswire/ — Anytime AI, the premier provider of AI-driven legal solutions, is proud to announce a strategic partnership... Read more.
JumpFly Elevates AI Capabilities to Drive Transformative Marketing Results
Top digital marketing agency JumpFly is expanding its AI capabilities to enhance campaign performance, improve efficiency, and deliver stronger results across digital... Read more.
U.S. Immigration Fund Welcomes Emily Zhu as Vice President of Business Development, Head of East Asia
PALM BEACH, Fla., April 30, 2025 /PRNewswire/ — U.S. Immigration Fund (USIF), a leading EB-5 Regional Center operator, is pleased to announce the addition... Read more.
Armilla Launches Affirmative AI Liability Insurance with Lloyd’s Underwriter, Chaucer
TORONTO, April 30, 2025 /PRNewswire/ – Armilla Insurance Services (Armilla), Coverholder at Lloyd’s, today announced the launch of its AI Liability... Read more.
Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial
– Reduced Relative Risk of 24-Week Confirmed Disability Worsening Events by 20% in Overall Study Population Compared to Placebo; Even More Prominent 30% Reduction... Read more.
Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Ras Inhibitor Resistant Lung Cancer at the 2025 AACR Annual Meeting
Both REQORSA Alone and in Combination with LUMAKRAS® Demonstrated Robust Anti-Tumor Effects in Ras Inhibitor Resistant Non-Small Cell Lung Cancer AUSTIN, Texas,... Read more.
Apertura Gene Therapy and Rett Syndrome Research Trust Collaborate to Pioneer Advanced Genetic Medicines for Rett Syndrome Using TfR1-Targeted AAV Capsid
NEW YORK and TRUMBULL, Conn., April 30, 2025 /PRNewswire/ — Apertura Gene Therapy, a biotechnology company focused on innovative gene therapy solutions, and... Read more.